Activ-6 Research Study

ACTIV-6 has concluded enrollment. As we continue to analyze results, we believe it's important to share the findings of each medication arm as soon as they are available. View results from 6 medications and dosages, and keep an eye out for more to be shared soon.
https://activ6study.org/study-results/

Even with vaccines more widely available, people in the U.S. are still getting sick with , and need to treat their symptoms. ACTIV-6 is testing repurposed drugs for at-home treatment of COVID. Learn more: https://activ6study.org

Thanks to ACTIV-6 participants and all those who participate in clinical research, we are able share results from what we are learning. Visit https://activ6study.org/study-results/ to read!

In the ACTIV-6 study, participants, researchers, and clinicians are working together to understand how we can help people with and prevent hospitalization. Learn more: https://activ6study.org

ACTIV-6 began its work in 2021 to identify repurposed drugs that may treat symptoms from home. Since then, we've shared results, publications, and enrolled over 10k participants.
Read more ACTIV-6 history and accomplishments: https://activ6study.org/activ-6-history-and-accomplishments/

Can we find medications that can be easily given at home to treat ? The ACTIV-6 study aims to provide answers to help people . See what we've learned at https://activ6study.org/study-results/

Clinical trials like ACTIV-6 help provide answers for using repurposed drugs to treat COVID-19 early in the disease and from home. Read more about repurposed drugs: https://activ6study.org/

ACTIV-6 has completed enrollment! Keep an eye out as we share findings from the metformin arm and overall study results soon.
https://activ6study.org/study-results/

ACTIV-6 is committed to sharing results. Visit the website to read the latest findings from this remote clinical seeking at-home treatments for . https://activ6study.org/study-results/

What makes ACTIV-6 unique? This clinical trial is testing repurposed drugs for treatment and is completely remote! Learn more about how ACTIV-6 studied medicines that might help people with COVID . https://activ6study.org

In ACTIV-6, participants, researchers, and clinicians are working together to understand how we can help people with and prevent hospitalization. Learn more: https://activ6study.org

In ACTIV-6, participants, researchers, and clinicians are working together to understand how we can help people with and prevent hospitalization. Learn more: https://activ6study.org/

ACTIV-6 is learning which already FDA-approved drugs can be used for treatment. The study has shared results for 6 drug dosages with more to come. Read on our website: http://activ6study.org/study-results/

Even with vaccines more widely available, people in the U.S. are still getting sick with , and need to treat their symptoms. ACTIV-6 is testing repurposed drugs for at-home treatment of COVID. Learn more: https://activ6study.org/

Want to learn more about the repurposed drugs that ACTIV-6 tested for at-home treatment of ? Visit https://activ6study.org/ to learn about each medication that was evaluated in the clinical trial.

There's an urgent need for medicines that can treat symptoms outside of the hospital. The NIH-sponsored ACTIV-6 study is testing repurposed drugs for at-home treatment. Learn more: https://activ6study.org/

ACTIV-6 continues to evaluate repurposed drugs that may treat at home. As new results become available, we are committed to sharing them.
Read results from past study arms: https://activ6study.org/study-results/

ACTIV-6 continues to research existing drugs that could treat symptoms from home. The current study arm is testing metformin, a medicine commonly used to treat diabetes.
Learn more at https://activ6study.org

ACTIV-6 continues to research existing drugs that could be used for treatment of symptoms from home. The current study arm is testing metformin, a medicine commonly used to treat diabetes. Learn more at https://activ6study.org

ACTIV-6 began its work in 2021 to identify repurposed drugs that may treat symptoms from home. Since then, we've shared results, publications, and enrolled over 10k participants. Read more ACTIV-6 history and accomplishments: https://activ6study.org/activ-6-history-and-accomplishments/

Participating in clinical trials like ACTIV-6 adds to scientific knowledge on diseases like . ACTIV-6 thanks its ongoing and past participants for their contributions. Learn more about what ACTIV-6 participation looked like: https://activ6study.org/the-activ-6-study/

ACTIV-6 met its enrollment goal and is now closed to new participants. Contact your study coordinator to ask questions on details of your participation. Keep an eye on https://activ6study.org as we continue to share study results!

ACTIV-6 is committed to sharing study results. Visit the website to read the latest study findings from this remote clinical seeking at-home treatments for . https://activ6study.org/study-results/

ACTIV-6 found no clinical benefit to taking 10 mg of montelukast for the treatment of mild-to-moderate symptoms.
Read study results from this clinical trial: https://dcri.org/news/study-confirms-no-benefit-taking-montelukast-covid-19-symptoms

Study Confirms No Benefit to Taking Montelukast for COVID-19 Symptoms Montelukast, commonly used to treat asthma and allergies, is one of five FDA-approved repurposed medications tested in ACTIV-6, a nationwide remote study May 22, 2024 – A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University found no symptomatic or clin...

What makes ACTIV-6 unique? This clinical trial is testing repurposed drugs for treatment and is completely remote! Learn more about how ACTIV-6 studied medicines that might help people with COVID . https://activ6study.org/

The ACTIV-6 study found no clinical benefit to taking 10 mg of montelukast for the treatment of mild-to-moderate COVID-19 symptoms. Read study results from this NIH clinical trial: https://dcri.org/news/study-confirms-no-benefit-taking-montelukast-covid-19-symptoms

The ACTIV-6 study has completed enrollment! Keep an eye out as we share findings from the final arm, metformin, soon, as well as overall study results.
https://activ6study.org/study-results/

ACTIV-6 continues to evaluate repurposed drugs that may treat at home. As results become available, we are committed to sharing them. Read new results from the arm testing montelukast: https://activ6study.org/study-results/